Enhancing immune responses of ESC-based TAA cancer vaccines with a novel OMV delivery system.

The TCR-seq findings showed a decreasing trend in the diversity of TCR clones in the OMV-PP group, indicating the expansion of specific TCR clones (Fig. 5 f).

also in 47,180 other papers